Tags

Type your tag names separated by a space and hit enter

Successful recovery of a patient with multiple myeloma from severe coronavirus disease 2019 (COVID-19) pneumonia during the first chemotherapy cycle: A case report.
Exp Ther Med. 2021 Apr; 21(4):392.ET

Abstract

A continuing outbreak of pneumonia associated with the 2019 novel coronavirus (2019-nCoV) was initially described in Wuhan, China in December 2019. Weak and elderly individuals, and those with chronic diseases such as hematological malignancies are prone to develop severe pneumonia. The humoral immunity of patients with multiple myeloma is prevalently low, and their inferior immunity further deteriorates during chemotherapy. For patients with onco-hematological malignancies infected with 2019-nCoV during the first chemotherapy cycle, the clinical treatment experience is lacking. The present study is a report of a 61-year-old patient newly diagnosed with multiple myeloma in the key 2019-nCoV outbreak area, who suffered severe 2019-nCoV pneumonia during the first chemotherapy cycle. The present case report demonstrated that a rapidly progressive and severe form of pneumonia was a specific clinical feature of COVID-19, especially in immunocompromised patients with cancer. The treatment strategy combining timely suspending chemotherapy, early intervention using intravenous immunoglobulin, interferon α inhalation and oral antiviral drugs was effective. Therefore, in the pandemic environment, it is strongly recommend that the risk of 2019-nCoV infection is assessed prior to chemotherapy.

Authors+Show Affiliations

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33680114

Citation

Li, Ziping, et al. "Successful Recovery of a Patient With Multiple Myeloma From Severe Coronavirus Disease 2019 (COVID-19) Pneumonia During the First Chemotherapy Cycle: a Case Report." Experimental and Therapeutic Medicine, vol. 21, no. 4, 2021, p. 392.
Li Z, Chen Y, Yang B, et al. Successful recovery of a patient with multiple myeloma from severe coronavirus disease 2019 (COVID-19) pneumonia during the first chemotherapy cycle: A case report. Exp Ther Med. 2021;21(4):392.
Li, Z., Chen, Y., Yang, B., Song, H., Chen, W., & Zhou, H. (2021). Successful recovery of a patient with multiple myeloma from severe coronavirus disease 2019 (COVID-19) pneumonia during the first chemotherapy cycle: A case report. Experimental and Therapeutic Medicine, 21(4), 392. https://doi.org/10.3892/etm.2021.9823
Li Z, et al. Successful Recovery of a Patient With Multiple Myeloma From Severe Coronavirus Disease 2019 (COVID-19) Pneumonia During the First Chemotherapy Cycle: a Case Report. Exp Ther Med. 2021;21(4):392. PubMed PMID: 33680114.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Successful recovery of a patient with multiple myeloma from severe coronavirus disease 2019 (COVID-19) pneumonia during the first chemotherapy cycle: A case report. AU - Li,Ziping, AU - Chen,Yan, AU - Yang,Bohan, AU - Song,Haiping, AU - Chen,Wanxin, AU - Zhou,Hao, Y1 - 2021/02/24/ PY - 2020/03/18/received PY - 2020/12/18/accepted PY - 2021/3/8/entrez PY - 2021/3/9/pubmed PY - 2021/3/9/medline KW - 2019 novel coronavirus KW - SARS-CoV-2 KW - coronavirus disease 2019 KW - multiple myeloma KW - severe pneumonia SP - 392 EP - 392 JF - Experimental and therapeutic medicine JO - Exp Ther Med VL - 21 IS - 4 N2 - A continuing outbreak of pneumonia associated with the 2019 novel coronavirus (2019-nCoV) was initially described in Wuhan, China in December 2019. Weak and elderly individuals, and those with chronic diseases such as hematological malignancies are prone to develop severe pneumonia. The humoral immunity of patients with multiple myeloma is prevalently low, and their inferior immunity further deteriorates during chemotherapy. For patients with onco-hematological malignancies infected with 2019-nCoV during the first chemotherapy cycle, the clinical treatment experience is lacking. The present study is a report of a 61-year-old patient newly diagnosed with multiple myeloma in the key 2019-nCoV outbreak area, who suffered severe 2019-nCoV pneumonia during the first chemotherapy cycle. The present case report demonstrated that a rapidly progressive and severe form of pneumonia was a specific clinical feature of COVID-19, especially in immunocompromised patients with cancer. The treatment strategy combining timely suspending chemotherapy, early intervention using intravenous immunoglobulin, interferon α inhalation and oral antiviral drugs was effective. Therefore, in the pandemic environment, it is strongly recommend that the risk of 2019-nCoV infection is assessed prior to chemotherapy. SN - 1792-0981 UR - https://www.unboundmedicine.com/medline/citation/33680114/Successful_recovery_of_a_patient_with_multiple_myeloma_from_severe_coronavirus_disease_2019__COVID_19__pneumonia_during_the_first_chemotherapy_cycle:_A_case_report_ DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.